Latest News

2017

The FTD Disorders Registry has launched!

2016

Swathi Devireddy, Ph.D. awarded the 2016 Bluefield Postdoctoral Fellowship 

Bluefield Project President Speaks at "Alzheimer's Disease-Related Dementias Summit 2016" 

2015

Constance Petit, Ph.D. awarded the 2015 Bluefield Postdoctoral Fellowship 

FORUM's Phase 2 Clinical Trial is Underway

2014

Phase 2 Clinical Trial for Progranulin-Deficient FTD Announced 

CFR Researchers Report Progranulin Protects Against Alzheimer Disease

NIH Rare Disease Clinical Research Network Grant for FTD Awarded

Vidhu Mathur, Ph.D. Awarded the 2014 Bluefield Postdoctoral Fellowship

CFR Researchers Discover Retinal Thinning is an Early Marker for Progranulin-Deficient FTD

FTD and Dr. Bruce Miller Featured on Carry the 1 Radio podcast

Family Hosts Memorial Fundraiser for The Bluefield Project

New Therapeutic Implications from Latest CFR Research

Couple Hikes Appalachian Trail to Benefit FTD Research

Drug Development Expert Ian Massey, Ph.D. to join Bluefield Scientific Advisory Board

2013

"Establishing Therapeutic Efficacy in Familial FTD" Conference Advances International Clinical Trials Network

2012

CFR Researchers Identify ALS and Frontotemporal Dementia Treatment Target

CFR Researchers Report Specific Defects in Frontotemporal Dementia Neurons

CFR Researchers Describe Potential Mechanism for How Loss of Progranulin Leads to Neuron Death

CFR Clinical Director Dr. Bruce Miller Wins Award; Public Lecture on 10/15/12

UCSF Frontotemporal Dementia Patient’s Remarkable Artistic Journey Profiled by Radiolab

CFR Research Featured in the New York Times

Meredith Judy, Ph.D. Awarded the 2012 Bluefield Postdoctoral Fellowship

The Bluefield Project to Cure Frontotemporal Dementia Announces New President Rodney Pearlman, Ph.D.

2012 CFR Discovery Meeting Highlights Collaborative Research

New Drug Demonstrates the Power of Patient and Research Foundation Advocacy

2011

CFR Investigator Dr. Bill Seeley Wins a MacArthur Genius Award

CFR Researchers Identify Drug that Raises Progranulin Levels

The Bluefield Project Awards its First Postdoctoral Fellowship

CFR Researchers Propose New Mechanism for Neurodegeneration in Frontotemporal Dementia

Tau and Tauopathies Workshop at the J. David Gladstone Institutes

2010

CFR Researchers Identify Key TDP-43 Partners

CFR Researchers Identify Regulator of Plasma Progranulin Levels

CFR Researchers Present at FTD2010 Meeting in Indianapolis

Biannual CFR Meeting Wrap-Up in San Francisco Bay Area